Polyclonal 90yttrium labeled antiferritin for refractory Hodgkin's disease
- 1 October 1989
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 17 (4) , 815-821
- https://doi.org/10.1016/0360-3016(89)90072-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Dosimetry and treatment planning for 90Y-labelled antiferritin in hepatomaInternational Journal of Radiation Oncology*Biology*Physics, 1988
- Concomitant illness in patients treated for Hodgkin's diseaseCancer Treatment Reviews, 1986
- Detection of specific anti-antibodies in patients treated with radiolabeled antibodyInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Allogeneic marrow transplantation in the treatment of MOPP-resistant Hodgkin's disease.Journal of Clinical Oncology, 1985
- Bone marrow transplantation as salvage therapy in advanced Hodgkin's disease: allogeneic or autologous.Journal of Clinical Oncology, 1985
- Patterns of care outcome studies: Results of the national practice in Hodgkin's diseaseCancer, 1983
- A dose and time response analysis of the treatment of Hodgkin's disease with MOPP chemotherapy.Journal of Clinical Oncology, 1983
- Dosimetry of 131I-labeled anti-ferritin in hepatoma: A model for radioimmunoglobulin dosimetryInternational Journal of Radiation Oncology*Biology*Physics, 1981
- Comprehensive Radiotherapy for Advanced Hodgkin's Disease Refractory to ChemotherapyTumori Journal, 1978
- HODGKIN'S DISEASEAmerican Journal of Roentgenology, 1967